AMAG features increased second-quarter revenues of $18.8 million to Feraheme AMAG Pharmaceuticals, Inc suhagra 100mg . , a biopharmaceutical organization focused on the advancement and commercialization of a therapeutic iron substance to treat iron insufficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2010. For the next one fourth, AMAG reported total income of $18.8 million, including $16. The MAA provides been deemed valid by the EMA and happens to be under review. Through the second one fourth, AMAG initiated enrollment in its global registrational program for Feraheme for the treating iron deficiency anemia, whatever the underlying cause.
It really is with great enjoyment that I proudly announce our partnership. Soft tissue lasers certainly are a must have for just about any cosmetic office. Your choice to choose Picasso as the distinctive laser for Aesthetic Advantage marks another example of a major, long-term romantic relationship and the continued industry interest in our growing and youthful company, said Alan Miller, CEO and President of AMD LASERS. Dr. Rosenthal can be an icon in the dental care arena and his status is world renowned as the ‘go-to-guy’ for cosmetics. I have the most respect for him and what he has done for our sector. Related StoriesRaising lupus recognition: an interview with Professor Ramsey-Goldman, MDReducing hospital readmissions through Transitional Care: an interview with Rani KhetarpalSurgical startup seeks financing to build virtual truth training library AMD LASERS provides positively changed the dental industry by providing affordable soft tissue laser beam technology on a worldwide scale.